Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  Esperite N.V. | Esperite (Life Sciences)

Six-month interim report (Q2) 2018

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  ALK-Abelló A/S

William Demant Holding A/S: Interim Report 2018

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  William Demant Holding A/S

Delivery of study drug to the PledOx® phase III program is expected in September

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  PledPharma AB

Rule 2.9 Announcement

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  ShangPharma Corp. (SHP) | Shire plc

Solon Eiendom ASA : Invitation to presentation of second quarter 2018 results

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018

PotNetwork Holdings, Inc. Reports 6-Month Revenues of over $12 Million, or More than Two Times  its Revenues for the Same Period in 2017

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018

Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  Aegis Therapeutics, LLC

Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility

DUBLIN, Aug. 15, 2018 /CNW/ -- Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA). The litigation, filed in the U.S. District Court for the District of Columbia in October 2017 by the... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  Endo International plc

Targovax ASA: Invitation to Second Quarter and First Half Year 2018 Results Presentation Thursday 23 August

OSLO, Norway, Aug 15, 2018 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, will announce its second quarter and first half year 2018 results on Thursday, 23 August 2018. A presentation... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018

Journal of Clinical Oncology Publishes That IMMray(TM) PanCan-d Serum Biomarker Test Detects Early Pancreatic Cancer With 96% Accuracy

LUND, Sweden, Aug. 15, 2018 /PRNewswire/ --Immunovia AB announced today that the prestigious Journal of Clinical Oncology (JCO) publishes the results of the major retrospective clinical validation study performed by Scandinavian and US researchers, showing that the IMMray(TM) PanCan-d serum biomarker... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  Immunovia AB

SIME Dx Announces New Design for Lung Maturity Diagnostic Device

LONDON, August 15, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  SIME Diagnostics Ltd.

Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1

CORK, Ireland, Aug. 15, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today confirmed positive topline results from the global, Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS) study of the first investigational long-acting injectable two-drug... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018

PEGylated Drugs Market in Europe and North America will achieve 5% CAGR to bypass $10.5 Billion by 2024

SELLBYVILLE, Del., August 15, 2018 /PRNewswire-iReach/ -- The North America & Europe PEGylated... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018

Perlara announces Glycogen Storage Diseases PerlQuest with the University of Notre Dame

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2018 /PRNewswire/ -- Perlara, a rare diseases drug discovery platform company partnering with highly motivated families and organizations, today announced a glycogen storage diseases collaboration with the University of Notre Dame and the Warren Family Research... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  Perlara, PBC | University of Notre Dame

Single Cell Analysis Market Worth $5.9 Billion by 2025 | CAGR 17.3%: Grand View Research, Inc.

SAN FRANCISCO, August 15, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Aug 2018

Elanco Animal Health Announces Pricing of $2.0 Billion of Senior Notes

INDIANAPOLIS, Aug. 14, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that its subsidiary, Elanco Animal Health Incorporated, has priced a private offering of $2.0 billion of senior notes (the "Offering"), consisting of $500 million aggregate principal amount of 3.912... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  Eli Lilly and Company

ViewRay Announces Pricing of Public Offering of Common Stock

CLEVELAND, Aug. 14, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 16,216,217 shares of common... Read more ››

By: PR Newswire Association LLC. - 15 Aug 2018
Related companies:  ViewRay Incorporated

Canopy Growth Corporation Reports First Quarter Fiscal 2019 Financial Results

Continued revenue acceleration with total first quarter revenue of $25.9 million representing a 63% increase over the quarter ended June 30, 2017 and a 14% increase over revenues of $22.8 million in the fourth quarter of fiscal 2018;

Read more ››
By: PR Newswire Association LLC. - 15 Aug 2018

Scythian Biosciences to Commence Trading on the Canadian Securities Exchange

Read more ››
By: Nasdaq / GlobenewsWire - 15 Aug 2018
Related companies:  Scythian Biosciences Corp.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑